Acceleron Pharma (XLRN) PT Raised to $109 at Cowen
Tweet Send to a Friend
Cowen analyst Yaron Werber raised the price target on Acceleron Pharma (NASDAQ: XLRN) to $109.00 (from $78.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
